{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:39:39Z","timestamp":1792517979189,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100019230","name":"Wuhan Union Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019230","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82573059"],"award-info":[{"award-number":["82573059"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303358"],"award-info":[{"award-number":["82303358"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82103611"],"award-info":[{"award-number":["82103611"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82573316"],"award-info":[{"award-number":["82573316"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.canlet.2026.218560","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T07:06:48Z","timestamp":1777964808000},"page":"218560","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["RNF43 deficiency activates YBX1-MYC-driven oxidative phosphorylation in pancreatic cancer"],"prefix":"10.1016","volume":"652","author":[{"given":"Gengdu","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penglin","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruozheng","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qixun","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heshui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9632-2597","authenticated-orcid":false,"given":"Yingke","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.canlet.2026.218560_bib1","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.1038\/s41467-020-18257-3","article-title":"A phospho-switch controls RNF43-mediated degradation of Wnt receptors to suppress tumorigenesis","volume":"11","author":"Tsukiyama","year":"2020","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.canlet.2026.218560_bib2","doi-asserted-by":"crossref","first-page":"376","DOI":"10.15283\/ijsc23070","article-title":"RNF43 and ZNRF3 in wnt signaling - a master regulator at the membrane","volume":"16","author":"Farnhammer","year":"2023","journal-title":"Int. J. Stem Cells"},{"issue":"7706","key":"10.1016\/j.canlet.2026.218560_bib3","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/s41586-018-0118-y","article-title":"RSPO2 inhibition of RNF43 and ZNRF3 governs limb development independently of LGR4\/5\/6","volume":"557","author":"Szenker-Ravi","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218560_bib4","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1038\/ncomms3787","article-title":"Structural and molecular basis of ZNRF3\/RNF43 transmembrane ubiquitin ligase inhibition by the Wnt agonist R-spondin","volume":"4","author":"Zebisch","year":"2013","journal-title":"Nat. Commun."},{"issue":"7413","key":"10.1016\/j.canlet.2026.218560_bib5","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/nature11308","article-title":"Tumour suppressor RNF43 is a stem-cell E3 ligase that induces endocytosis of Wnt receptors","volume":"488","author":"Koo","year":"2012","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.canlet.2026.218560_bib6","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/ng.3127","article-title":"RNF43 is frequently mutated in colorectal and endometrial cancers","volume":"46","author":"Giannakis","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2026.218560_bib7","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/1457452","article-title":"RNF43 mutations in IPMN cases: a potential prognostic factor","volume":"2020","author":"Chang","year":"2020","journal-title":"Gastroenterol. Res. Pract."},{"issue":"1","key":"10.1016\/j.canlet.2026.218560_bib8","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/ame2.12203","article-title":"Deficient Rnf43 potentiates hyperactive Kras-mediated pancreatic preneoplasia initiation and malignant transformation","volume":"5","author":"Zhou","year":"2022","journal-title":"Animal Model. Exp. Med."},{"issue":"31","key":"10.1016\/j.canlet.2026.218560_bib9","doi-asserted-by":"crossref","first-page":"12649","DOI":"10.1073\/pnas.1307218110","article-title":"Inactivating mutations of RNF43 confer Wnt dependency in pancreatic ductal adenocarcinoma","volume":"110","author":"Jiang","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.canlet.2026.218560_bib10","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41416-021-01389-8","article-title":"Phase 1 study of single-agent WNT974, a first-in-class Porcupine inhibitor, in patients with advanced solid tumours","volume":"125","author":"Rodon","year":"2021","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.canlet.2026.218560_bib11","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/wrna.1200","article-title":"YB-1 protein: functions and regulation","volume":"5","author":"Lyabin","year":"2014","journal-title":"Wiley Interdiscip. Rev.: RNA"},{"issue":"7","key":"10.1016\/j.canlet.2026.218560_bib12","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/bies.10300","article-title":"The pleiotropic functions of the Y-box-binding protein, YB-1","volume":"25","author":"Kohno","year":"2003","journal-title":"Bioessays : news and reviews in molecular, cellular and developmental biology"},{"issue":"2","key":"10.1016\/j.canlet.2026.218560_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25020717","article-title":"Y-Box binding protein 1: unraveling the multifaceted role in cancer development and therapeutic potential","volume":"25","author":"Dinh","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.canlet.2026.218560_bib14","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/s41375-021-01393-0","article-title":"YBX1 mediates translation of oncogenic transcripts to control cell competition in AML","volume":"36","author":"Perner","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.canlet.2026.218560_bib15","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.omto.2020.03.006","article-title":"Overexpression of YBX1 promotes pancreatic ductal adenocarcinoma growth via the GSK3B\/Cyclin D1\/Cyclin E1 pathway","volume":"17","author":"Liu","year":"2020","journal-title":"Mol. Ther. Oncolytics"},{"issue":"3","key":"10.1016\/j.canlet.2026.218560_bib16","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.gendis.2015.05.001","article-title":"Role of post-translational modification of the Y box binding protein 1 in human cancers","volume":"2","author":"Prabhu","year":"2015","journal-title":"Genes Dis."},{"issue":"11","key":"10.1016\/j.canlet.2026.218560_bib17","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.7150\/jca.56262","article-title":"RNA-binding protein YBX1 promotes cell proliferation and invasiveness of nasopharyngeal carcinoma cells via binding to AURKA mRNA","volume":"12","author":"Ban","year":"2021","journal-title":"J. Cancer"},{"key":"10.1016\/j.canlet.2026.218560_bib18","article-title":"Long non-coding RNA aerrie controls DNA damage repair via YBX1 to maintain endothelial cell function","volume":"8","author":"Pham","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"issue":"24","key":"10.1016\/j.canlet.2026.218560_bib19","doi-asserted-by":"crossref","first-page":"4246","DOI":"10.1158\/0008-5472.CAN-23-3596","article-title":"CircRREB1 mediates Metabolic reprogramming and stemness maintenance to facilitate pancreatic ductal adenocarcinoma progression","volume":"84","author":"Rong","year":"2024","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.canlet.2026.218560_bib20","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/s41556-022-00857-4","article-title":"Gasdermin E mediates resistance of pancreatic adenocarcinoma to enzymatic digestion through a YBX1-mucin pathway","volume":"24","author":"Lv","year":"2022","journal-title":"Nat. Cell Biol."},{"issue":"11","key":"10.1016\/j.canlet.2026.218560_bib21","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1038\/s42255-023-00927-3","article-title":"A century of the Warburg effect","volume":"5","author":"Thompson","year":"2023","journal-title":"Nat. Metab."},{"issue":"5930","key":"10.1016\/j.canlet.2026.218560_bib22","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.canlet.2026.218560_bib23","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1158\/1078-0432.CCR-17-3070","article-title":"Oxidative phosphorylation as an emerging target in cancer therapy","volume":"24","author":"Ashton","year":"2018","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.canlet.2026.218560_bib24","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40170-024-00342-6","article-title":"Characterizing OXPHOS inhibitor-mediated alleviation of hypoxia using high-throughput live cell-imaging","volume":"12","author":"Beerkens","year":"2024","journal-title":"Cancer Metabol."},{"issue":"3","key":"10.1016\/j.canlet.2026.218560_bib25","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.cmet.2021.01.014","article-title":"Transient phases of OXPHOS inhibitor resistance reveal underlying metabolic heterogeneity in single cells","volume":"33","author":"Kosaisawe","year":"2021","journal-title":"Cell Metab."},{"issue":"5","key":"10.1016\/j.canlet.2026.218560_bib26","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s10637-022-01277-9","article-title":"First-in-human study of IM156, a novel potent biguanide oxidative phosphorylation (OXPHOS) inhibitor, in patients with advanced solid tumors","volume":"40","author":"Janku","year":"2022","journal-title":"Invest. N. Drugs"},{"issue":"3","key":"10.1016\/j.canlet.2026.218560_bib27","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.cell.2012.01.058","article-title":"Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism","volume":"149","author":"Ying","year":"2012","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.canlet.2026.218560_bib28","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1038\/s41375-021-01489-7","article-title":"MYC, mitochondrial metabolism and O-GlcNAcylation converge to modulate the activity and subcellular localization of DNA and RNA demethylases","volume":"36","author":"Lin","year":"2022","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.canlet.2026.218560_bib29","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1261\/rna.1175909","article-title":"Control of c-myc mRNA stability by IGF2BP1-associated cytoplasmic RNPs","volume":"15","author":"Weidensdorfer","year":"2009","journal-title":"RNA (New York, NY)"},{"issue":"3","key":"10.1016\/j.canlet.2026.218560_bib30","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.cell.2022.01.003","article-title":"Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients","volume":"185","author":"Nguyen","year":"2022","journal-title":"Cell"},{"issue":"24","key":"10.1016\/j.canlet.2026.218560_bib31","doi-asserted-by":"crossref","first-page":"5619","DOI":"10.1158\/0008-5472.CAN-20-0957","article-title":"The functional landscape of patient-derived RNF43 mutations predicts sensitivity to wnt inhibition","volume":"80","author":"Yu","year":"2020","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.canlet.2026.218560_bib32","doi-asserted-by":"crossref","first-page":"4848","DOI":"10.1038\/s41467-025-60096-7","article-title":"WNT-induced association of Frizzled and LRP6 is not sufficient for the initiation of WNT\/\u03b2-catenin signaling","volume":"16","author":"Voss","year":"2025","journal-title":"Nat. Commun."},{"issue":"17","key":"10.1016\/j.canlet.2026.218560_bib33","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.1038\/s41388-020-1232-5","article-title":"Commonly observed RNF43 mutations retain functionality in attenuating Wnt\/\u03b2-catenin signaling and unlikely confer Wnt-dependency onto colorectal cancers","volume":"39","author":"Li","year":"2020","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.canlet.2026.218560_bib34","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/path.5868","article-title":"Characterization of RNF43 frameshift mutations that drive Wnt ligand- and R-spondin-dependent colon cancer","volume":"257","author":"Yamamoto","year":"2022","journal-title":"J. Pathol."},{"issue":"1","key":"10.1016\/j.canlet.2026.218560_bib35","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s12943-024-02119-3","article-title":"Altered metabolism in cancer: insights into energy pathways and therapeutic targets","volume":"23","author":"Tufail","year":"2024","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.canlet.2026.218560_bib36","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41571-021-00549-2","article-title":"The MYC oncogene - the grand orchestrator of cancer growth and immune evasion","volume":"19","author":"Dhanasekaran","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030438352600323X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030438352600323X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:01:04Z","timestamp":1792515664000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030438352600323X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":36,"alternative-id":["S030438352600323X"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218560","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RNF43 deficiency activates YBX1-MYC-driven oxidative phosphorylation in pancreatic cancer","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218560","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"218560"}}